Insider Transactions in Q4 2021 at Cyclo Therapeutics, Inc. (CYTH)

Date	Insider	Transaction	Ownership Type	Shares Traded	Value / Price
Dec 15 2021	N Scott Fine Chief Executive Officer	BUY Open market or private purchase	Direct	5,000 +3.71%	$15,000 $3.89 P/Share
Dec 15 2021	Francis Patrick Ostronic Director	BUY Open market or private purchase	Direct	3,000 +2.75%	$9,000 $3.9 P/Share
Dec 10 2021	Francis Patrick Ostronic Director	BUY Open market or private purchase	Direct	5,000 +4.62%	$20,000 $4.4 P/Share
Dec 03 2021	Francis Patrick Ostronic Director	BUY Open market or private purchase	Direct	864 +0.87%	$3,456 $4.75 P/Share
Dec 02 2021	Francis Patrick Ostronic Director	BUY Open market or private purchase	Direct	4,136 +4.08%	$16,544 $4.75 P/Share
Dec 02 2021	N Scott Fine Chief Executive Officer	BUY Open market or private purchase	Direct	5,000 +3.86%	$20,000 $4.93 P/Share
Dec 02 2021	Sharon Hemond Hrynkow Chief Scientific Officer	BUY Open market or private purchase	Direct	1,000 +4.91%	$4,000 $4.98 P/Share
Dec 01 2021	Francis Patrick Ostronic Director	BUY Open market or private purchase	Direct	5,000 +5.09%	$25,000 $5.0 P/Share
Nov 19 2021	Francis Patrick Ostronic Director	BUY Open market or private purchase	Direct	10,652 +5.5%	$53,260 $5.24 P/Share
Nov 19 2021	N Scott Fine Chief Executive Officer	BUY Open market or private purchase	Direct	5,000 +4.01%	$25,000 $5.25 P/Share
Oct 29 2021	Francis Patrick Ostronic Director	BUY Open market or private purchase	Direct	1,000 +1.27%	$5,000 $5.9 P/Share

Receive a notification when an Institution or Guru buys or sells CYTH shares.

Notify only if

Value

Get notified when an Cyclo Therapeutics, Inc. insider buys or sells CYTH shares.

Notify only if

Operation

Value

Type

Receive news related to Cyclo Therapeutics, Inc.